Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
PLoS One. 2007 May 23;2(5):e458. doi: 10.1371/journal.pone.0000458.
Plasmacytoid dendritic cells (pDCs) are important mediators of innate immunity that act mainly through secretion of interferon (IFN)-alpha. Previous studies have found that these cells can suppress HIV in vitro; additionally, pDCs have been shown to be severely reduced in the peripheral blood of HIV-infected individuals. In the present study, we sought to determine the ability of pDCs to directly suppress viral replication ex vivo and to delineate the potential mechanisms whereby pDCs are depleted in HIV-infected individuals. We demonstrate that activated pDCs strongly suppress HIV replication in autologous CD4(+) T cells via a mechanism involving IFN-alpha as well as other antiviral factors. Of note, unstimulated pDCs from infected individuals who maintain low levels of plasma viremia without antiretroviral therapy were able to suppress HIV ex vivo via a mechanism requiring cell-to-cell contact. Our data also demonstrate that death of pDCs by both apoptosis and necrosis is induced by fusion of HIV with pDCs. Taken together, our data suggest that pDCs play an important role in the control of HIV replication and that high levels of viral replication in vivo are associated with pDC cell death via apoptosis and necrosis. Elucidation of the mechanism by which pDCs suppress HIV replication in vivo may have clinically relevant implications for future therapeutic strategies.
浆细胞样树突状细胞 (pDCs) 是先天免疫的重要介质,主要通过分泌干扰素 (IFN)-α 发挥作用。先前的研究发现,这些细胞可以在体外抑制 HIV;此外,已发现 HIV 感染个体的外周血中 pDCs 严重减少。在本研究中,我们试图确定 pDCs 直接抑制病毒复制的能力,并阐明 HIV 感染个体中 pDCs 耗竭的潜在机制。我们证明,通过涉及 IFN-α 以及其他抗病毒因子的机制,激活的 pDCs 可强烈抑制自体 CD4(+) T 细胞中的 HIV 复制。值得注意的是,在未接受抗逆转录病毒治疗但血浆病毒载量保持低水平的感染个体中,未受刺激的 pDCs 能够通过需要细胞间接触的机制在体外抑制 HIV。我们的数据还表明,HIV 与 pDCs 融合会诱导 pDCs 通过凋亡和坏死死亡。总之,我们的数据表明,pDCs 在控制 HIV 复制中发挥重要作用,体内高病毒复制与通过凋亡和坏死导致的 pDC 细胞死亡有关。阐明 pDCs 在体内抑制 HIV 复制的机制可能对未来的治疗策略具有临床相关意义。